Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-20

FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for clopidogrel bisulfate manufactured by Aurobindo Pharma Limited, enabling continued marketing of this generic pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

SUPPL AP for CLOPIDOGREL (CLOPIDOGREL BISULFATE)